Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 15, 2024

SELL
$197.69 - $227.29 $158,152 - $181,832
-800 Reduced 18.18%
3,600 $818 Million
Q3 2023

Feb 06, 2024

BUY
$201.05 - $221.7 $884,620 - $975,480
4,400 New
4,400 $885 Million
Q2 2023

Apr 05, 2024

BUY
$211.93 - $241.33 $127,158 - $144,798
600 Added 15.79%
4,400 $1.06 Billion
Q2 2022

Apr 05, 2024

SELL
$213.86 - $277.87 $213,860 - $277,870
-1,000 Reduced 20.83%
3,800 $891 Million
Q1 2021

Apr 05, 2024

BUY
$204.88 - $255.03 $225,368 - $280,533
1,100 Added 29.73%
4,800 $1.22 Billion
Q3 2020

Apr 05, 2024

BUY
$167.03 - $201.3 $133,624 - $161,040
800 Added 27.59%
3,700 $697 Million
Q1 2020

Apr 05, 2024

SELL
$104.32 - $195.28 $250,367 - $468,672
-2,400 Reduced 45.28%
2,900 $367 Million
Q4 2019

Apr 05, 2024

BUY
$163.48 - $173.61 $441,396 - $468,747
2,700 Added 103.85%
5,300 $897 Million
Q2 2019

Apr 05, 2024

BUY
$144.16 - $172.9 $374,816 - $449,540
2,600 New
2,600 $450 Million
Q4 2018

Apr 05, 2024

SELL
$120.82 - $174.09 $386,624 - $557,088
-3,200 Closed
0 $0
Q2 2018

Apr 05, 2024

BUY
$160.33 - $189.41 $112,231 - $132,587
700 Added 28.0%
3,200 $574 Million
Q4 2017

Apr 05, 2024

SELL
$147.99 - $163.95 $103,593 - $114,764
-700 Reduced 21.88%
2,500 $399 Million
Q3 2017

Apr 05, 2024

BUY
$149.47 - $160.56 $14,947 - $16,056
100 Added 3.23%
3,200 $483 Million
Q1 2017

Apr 05, 2024

BUY
N/A
900 Added 40.91%
3,100 $445 Million
Q1 2012

Apr 05, 2024

BUY
N/A
1,100 Added 100.0%
2,200 $201 Million
Q4 2011

Apr 05, 2024

SELL
N/A
-1,300 Reduced 54.17%
1,100 $94.6 Million
Q2 2010

Apr 05, 2024

BUY
N/A
1,000 Added 71.43%
2,400 $181 Million
Q4 2006

Apr 05, 2024

SELL
N/A
-2,200
1,400 $103 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.5B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track E. Ohman J:Or Asset Management Ab Portfolio

Follow E. Ohman J:Or Asset Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of E. Ohman J:Or Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on E. Ohman J:Or Asset Management Ab with notifications on news.